Rane Pharmaceutical Inc.

Published purpose

Rane Pharmaceutical has been actively involved in lipid manufacturing since 2016. During the recent Covid-19 pandemic, some novel lipid molecules became the key ingredient in developing mRNA and DNA-based vaccines against Covid-19 (SARS-CoV-2). There is also an increased interest in expanding the mRNA/DNA-based therapies into developing novel drugs for cancer and other rare diseases. We plan to meet this increased demand by developing our large-scale production capacity and investing in additional resources (Scientist / Business development and Infrastructure) to create rare and novel lipids. Dedicated business development staff will be hired to develop strategies to expand and reach international markets.